The US Congress passes the Competitive Health Insurance Reform Act limiting the antitrust exemption available to companies under the McCarran-Ferguson Act

In Short The Development: Congress unanimously passed and before leaving office, President Trump signed into law, the Competitive Health Insurance Reform Act ("CHIRA"). CHIRA limits application of the McCarran-Ferguson Act, an exemption from the federal antitrust laws, as it relates to the business of health insurance. The Context: Since 1945, the McCarran-Ferguson Act has exempted certain conduct of insurers from challenge under the federal antitrust laws. State insurance regulators and the health insurance industry's trade group have long maintained that repealing the McCarran‑Ferguson Act is unnecessary, in part, because state antitrust and insurance laws already prohibit conduct such as price fixing that CHIRA proponents claim that McCarran-Ferguson insulates. Looking Ahead: In

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Catherine E. Livingston, James Lenahan Poth, Aimee DeFilippo, Kenneth W. Field, Michael A. Gleason, Lisa Han, David Kiernan, Margaret A. Ward, The US Congress passes the Competitive Health Insurance Reform Act limiting the antitrust exemption available to companies under the McCarran-Ferguson Act, 13 January 2021, e-Competitions January 2021, Art. N° 98992

Visites 56

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues